BTK inhibitor
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for BTK inhibitor, covering 2018-08-22 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma [Phase 1]